J. Lococo

Open-label assessment of levofloxacin for the treatment of acute bacterial sinusitis in adults.

T. A. Sydnor, C. Fowler, S. S. Kim, 1998, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

In vitro and in vivo antibacterial activities of FK037, a novel parenteral broad-spectrum cephalosporin

B. Foleno, K. Fu, J. Lococo, 1993, Antimicrobial Agents and Chemotherapy.

In vitro and in vivo antidermatophytic activity of saperconazole, a new fluorinated triazole.

B. Foleno, J. Hilliard, K. Fu, 1992, Drugs under experimental and clinical research.

Suppression of estrogen-withdrawal headache with extended transdermal contraception.

A. Fisher, K. Laguardia, A. Friedman, 2005, Fertility and sterility.

On-Demand Proton Pump Inhibitory Treatment in Overweight/Obese Patients with Gastroesophageal Reflux Disease: Are There Pharmacodynamic Arguments for Using Higher Doses?

P. Ducrotte, S. Bruley des Varannes, J. Xiang, 2013, Digestion.

Effects of a single dose of rabeprazole 20 mg and pantoprazole 40 mg on 24‐h intragastric acidity and oesophageal acid exposure: a randomized study in gastro‐oesophageal reflux disease patients with a history of nocturnal heartburn

J. Ieni, J. Xiang, P. Miner, 2010, Alimentary pharmacology & therapeutics.

Does BMI affect the clinical efficacy of proton pump inhibitor therapy in GERD? The case for rabeprazole

F. Pace, C. Scarpignato, J. Xiang, 2011, European journal of gastroenterology & hepatology.

Does BMI affect the clinical efficacy of proton pump inhibitor therapy in GERD? The case for rabeprazole

F. Pace, C. Scarpignato, J. Xiang, 2011, European journal of gastroenterology & hepatology.